Related Experiment Video
Updated: Aug 20, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Prognostic Importance of Atrial Fibrillation and Anticoagulation in Alcoholic Versus Dilated Cardiomyopathy
Alan Manivannan1, Morten Schou2, Kevin M Monahan2
1Department of Medicine, Section of Internal Medicine, Boston University Medical Center, Boston, MA, USA.
Insights
Patients with alcoholic cardiomyopathy (ACM) face a worse prognosis than those with dilated cardiomyopathy (DCM), irrespective of atrial fibrillation (AF). Oral anticoagulation offers similar benefits for both ACM and DCM patients.
Area of Science:
- Cardiology
- Internal Medicine
- Pharmacology
Background:
- Alcoholic cardiomyopathy (ACM) and dilated cardiomyopathy (DCM) are significant heart conditions.
- Atrial fibrillation (AF) is a common comorbidity in cardiac diseases.
- Limited data exist on the comparative prognosis of AF and oral anticoagulation in ACM versus DCM.
Purpose of the Study:
- To compare the prognostic impact of atrial fibrillation (AF) in patients with alcoholic cardiomyopathy (ACM) versus dilated cardiomyopathy (DCM).
- To assess the effectiveness of oral anticoagulation in patients with ACM compared to DCM.
- To investigate mortality differences following anticoagulation initiation in both ACM and DCM populations.
Main Methods:
- A nationwide cohort analysis using Danish registries from 1994-2018.
- Inclusion of 1237 patients with ACM and 17,211 individuals with DCM.
- Assessment of prognostic differences and mortality rates with and without AF, and following oral anticoagulation initiation.
Main Results:
- Patients with ACM were younger, more often male, and had a greater cumulative 5-year mortality than DCM patients, irrespective of AF.
- The prognosis associated with AF differed significantly between ACM and DCM.
- Oral anticoagulation demonstrated similar mortality benefits in both ACM and DCM cohorts.
Conclusions:
- Alcoholic cardiomyopathy (ACM) is associated with a worse prognosis compared to dilated cardiomyopathy (DCM).
- Atrial fibrillation (AF) does not appear to be the primary driver of the worse prognosis in ACM.
- Oral anticoagulation provides comparable risk reduction benefits for patients with ACM and DCM.
Aims:
Limited data exist to describe the prognostic impact of atrial fibrillation (AF) and oral anticoagulation on patients with alcoholic cardiomyopathy (ACM) compared with dilated cardiomyopathy (DCM) and were investigated in this study.
Methods:
Using Danish nationwide registries, a cohort analysis was conducted to assess the prognostic differences for patients with a first diagnosis of ACM versus DCM with and without AF 1994-2018 (followed until end 2019). Our study also assessed differences in mortality following initiation of anticoagulation in both populations.
Results:
Totally, 1237 patients with ACM (33% with AF) and 17,211 individuals with DCM (33% with AF) were included. Those with ACM were more often men (89 versus 71%) and younger than patients with DCM (mean age 56 versus 64 years). Cumulative 5-year mortality was greater among patients with ACM, compared with DCM, regardless of AF (ACM with AF 49% [95% CI: 44-54%], ACM without AF 48% [45-53%], DCM with AF 41% [39-42%], DCM without AF 30% [29-31%], P < 0.0001). The prognosis associated with AF was statistically significantly different in people with ACM and DCM (adjusted hazards ratio 0.85 [95% CI: 0.74-0.98] versus 1.04 [1.00-1.09] in ACM and DCM, P < 0.0001). The mortality associated with oral anticoagulation was similar in ACM and DCM (hazards ratio 0.81 [0.61-1.07] versus 0.87 [0.80-0.94], P = 0.49).
Conclusions:
Patients with ACM had a worse prognosis when compared with patients with DCM, but this did not appear to be driven by AF. Patients with ACM were observed to have similar associated risk benefits of oral anticoagulation as DCM.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management

